Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system

Journal of Molecular and Cellular Cardiology

Volumn 77, Issue , 2014, Pages 73-85

  Yamauchi, Akihiro ^a   Sakurai, Takayuki ^a   Kamiyoshi, Akiko ^a   Ichikawa Shindo, Yuka ^a   Kawate, Hisaka ^a   Igarashi, Kyoko ^a   Toriyama, Yuichi ^a   Tanaka, Megumu ^a   Liu, Tian ^a   Xian, Xian ^a   Imai, Akira ^a   Zhai, Liuyu ^a   Owa, Shinji ^a   Arai, Takuma ^a   Shindo, Takayuki ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenomedullin (AM); Angiogenesis; Knockout mice; Lymphatic drainage; Receptor activity modifying protein (RAMP)

Indexed keywords

RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; RAMP2 PROTEIN, MOUSE; RAMP3 PROTEIN, MOUSE;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CARDIOVASCULAR SYSTEM; CELL MIGRATION; CELL PROLIFERATION; CHYLE; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; ENTEROPATHY; INFLAMMATORY CELL; INTESTINE LYMPH; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC DRAINAGE; LYMPHEDEMA; MALE; MOLECULAR PATHOLOGY; MOUSE; NEWBORN; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VASCULAR DISEASE; VASODILATATION; WILD TYPE; ANIMAL; CANCER TRANSPLANTATION; COMPARATIVE STUDY; FEMALE; GENETICS; HINDLIMB; ISCHEMIA; KNOCKOUT MOUSE; LETHAL GENE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL LINE; VASCULARIZATION;

MUS;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOTHELIUM, LYMPHATIC; FEMALE; GENES, LETHAL; HINDLIMB; ISCHEMIA; LYMPHEDEMA; MALE; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3;

EID: 84908322673     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.09.017     Document Type: Article

References (38)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993, 192:553-560.
2. Jougasaki M., Wei C.M., Aarhus L.L., Heublein D.M., Sandberg S.M., Burnett J.C. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995, 268:F657-F663.
3. Nishikimi T., Matsuoka H. Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. Curr Med Chem Cardiovasc Hematol Agents 2005, 3:231-242.
4. Samson W.K., Murphy T., Schell D.A. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 1995, 136:2349-2352.
5. Petrie M.C., Hillier C., Morton J.J., McMurray J.J. Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. J Hypertens 2000, 18:61-64.
6. Isumi Y., Kubo A., Katafuchi T., Kangawa K., Minamino N. Adrenomedullin suppresses interleukin-1beta-induced tumor necrosis factor-alpha production in Swiss 3T3 cells. FEBS Lett 1999, 463:110-114.
7. Shimosawa T., Shibagaki Y., Ishibashi K., Kitamura K., Kangawa K., Kato S., et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002, 105:106-111.
8. Shimosawa T., Ogihara T., Matsui H., Asano T., Ando K., Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 2003, 41:1080-1085.
9. Kano H., Kohno M., Yasunari K., Yokokawa K., Horio T., Ikeda M., et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 1996, 14:209-213.
10. Miyashita K., Itoh H., Sawada N., Fukunaga Y., Sone M., Yamahara K., et al. Adrenomedullin promotes proliferation and migration of cultured endothelial cells. Hypertens Res 2003, (26 Suppl.):S93-S98.
11. Iwasaki H., Eguchi S., Shichiri M., Marumo F., Hirata Y. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 1998, 139:3432-3441.
12. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339.
13. Kuwasako K., Cao Y.N., Nagoshi Y., Kitamura K., Eto T. Adrenomedullin receptors: pharmacological features and possible pathophysiological roles. Peptides 2004, 25:2003-2012.
14. Morfis M., Christopoulos A., Sexton P.M. RAMPs: 5years on, where to now?. Trends Pharmacol Sci 2003, 24:596-601.
15. Parameswaran N., Spielman W.S. RAMPs: the past, present and future. Trends Biochem Sci 2006, 31:631-638.
16. Shindo T., Kurihara Y., Nishimatsu H., Moriyama N., Kakoki M., Wang Y., et al. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001, 104:1964-1971.
17. Ichikawa-Shindo Y., Sakurai T., Kamiyoshi A., Kawate H., Iinuma N., Yoshizawa T., et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest 2008, 118:29-39.
18. Koyama T., Ochoa-Callejero L., Sakurai T., Kamiyoshi A., Ichikawa-Shindo Y., Iinuma N., et al. Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis. Circulation 2013, 127:842-853.
19. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M. Mouse model of angiogenesis. Am J Pathol 1998, 152:1667-1679.
20. Jin D., Harada K., Ohnishi S., Yamahara K., Kangawa K., Nagaya N. Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema. Cardiovasc Res 2008, 80:339-345.
21. Kazenwadel J., Secker G.A., Betterman K.L., Harvey N.L. In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis. PLoS One 2012, 7:e40497.
22. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007, 2:329-333.
23. Iimuro S., Shindo T., Moriyama N., Amaki T., Niu P., Takeda N., et al. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ Res 2004, 95:415-423.
24. Nikitenko L.L., Shimosawa T., Henderson S., Makinen T., Shimosawa H., Qureshi U., et al. Adrenomedullin haploinsufficiency predisposes to secondary lymphedema. J Invest Dermatol 2013, 133:1768-1776.
25. Hoopes S.L., Willcockson H.H., Caron K.M. Characteristics of multi-organ lymphangiectasia resulting from temporal deletion of calcitonin receptor-like receptor in adult mice. PLoS One 2012, 7:e45261.
26. Yamamoto T., Narushima M., Doi K., Oshima A., Ogata F., Mihara M., et al. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg 2011, 127:1979-1986.
27. Kwon S., Sevick-Muraca E.M. Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol 2007, 5:219-231.
28. Buettner M., Bode U. Lymph node dissection - understanding the immunological function of lymph nodes. Clin Exp Immunol 2012, 169:205-212.
29. Dixon J.B. Lymphatic lipid transport: sewer or subway?. Trends Endocrinol Metab 2010, 21:480-487.
30. Blum K.S., Proulx S.T., Luciani P., Leroux J.C., Detmar M. Dynamics of lymphatic regeneration and flow patterns after lymph node dissection. Breast Cancer Res Treat 2013, 139:81-86.
31. Shao L., Mori S., Yagishita Y., Okuno T., Hatakeyama Y., Sato T., et al. Lymphatic mapping of mice with systemic lymphoproliferative disorder: usefulness as an inter-lymph node metastasis model of cancer. J Immunol Methods 2013, 389:69-78.
32. Huggenberger R., Ullmann S., Proulx S.T., Pytowski B., Alitalo K., Detmar M. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 2010, 207:2255-2269.
33. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol 2010, 88:1157-1162.
34. Boardman K.C., Swartz M.A. Interstitial flow as a guide for lymphangiogenesis. Circ Res 2003, 92:801-808.
35. Miyashita K., Itoh H., Sawada N., Fukunaga Y., Sone M., Yamahara K., et al. Adrenomedullin provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Lett 2003, 544:86-92.
36. Maegawa J., Yabuki Y., Tomoeda H., Hosono M., Yasumura K. Outcomes of lymphaticovenous side-to-end anastomosis in peripheral lymphedema. J Vasc Surg 2012, 55:753-760.
37. Demirtas Y., Ozturk N., Yapici O., Topalan M. Supermicrosurgical lymphaticovenular anastomosis and lymphaticovenous implantation for treatment of unilateral lower extremity lymphedema. Microsurgery 2009, 29:609-618.
38. Tammela T., Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140:460-476.